6th Annual RAS-Targeted Drug Development Summit
Evvnt Promotion / evvnt
Archivio
24.09.2024 - 26.09.2024 Hilton Boston Park Plaza, 50 Park Plaza, 02116 Boston, Massachusetts, USA
Time: 8:00 AM - 4:45 PM
Temi della conferenza
Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology
With tumor and patient heterogeneity, the quest to target the remaining RAS mutants continues, and now more than ever, we are witnessing this industry make great strides in utilizing novel modalities and elucidating mechanisms of resistance.
Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology
With tumor and patient heterogeneity, the quest to target the remaining RAS mutants continues, and now more than ever, we are witnessing this industry make great strides in utilizing novel modalities and elucidating mechanisms of resistance.
Professional congress organizer (PCO)
Hanson Wade Group
Hanson Wade Group
Annotazioni
URL:
Brochure: https://go.evvnt.com/2464057-3?pid=4832
Speakers: Ahmadur Rahman, Senior Clinical Director and Clinical Science Lead, Global Oncology Research and Development, Roche, and more
URL:
Brochure: https://go.evvnt.com/2464057-3?pid=4832
Speakers: Ahmadur Rahman, Senior Clinical Director and Clinical Science Lead, Global Oncology Research and Development, Roche, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2464057-2?pid=4832
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
